Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors in the central nervous method, conolidine modulates alternate molecular targets. A Science Advances research found that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://what-is-the-best-conolidi70216.dgbloggers.com/38976195/the-2-minute-rule-for-conolidin-to-replace-traditional-painkillers